5: Inozyme Pharma, Inc. $INZY
Market cap: $12.25M
Inozyme Pharma is a clinical-stage biopharmaceutical company developing novel enzyme-based therapeutics for the treatment of rare metabolic diseases. The company's stock has been on the rise lately due to a recent announcement of positive data from a pre-clinical study of its lead product candidate.
I asked, “What Smallcap stock you think can be next 10x multibagger in 3-5 years?”
I received 600 answers
Here are 5 top stocks that have 10x+ potential:
4: Prana Biotechnology Ltd. $PRNB
Market cap: $17.28M
Prana Biotechnology is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer and other diseases. The company's stock has been on the rise lately due to a recent announcement of a new clinical trial of its lead product candidate.
Originally published on 20 May 1570, the Theatrum Orbis Terrarum (or "Theatre of the World") is considered the first modern atlas.
#world#atlas#vintage